Patent Assignment
Reel/Frame 040575/0110
Security Interest
Recorded: 2016-11-07
Pages: 212
Assignor
OMEROS CORPORATION
Executed: 2016-11-03
Assignee
CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
1000 MAIN STREET, SUITE 2500, HOUSTON, TEXAS, 77002
Covered Properties
(123)
Inducible Mutagenesis of Target Genes
Composition and Method for Diversification of Target Sequences
Anti-FZD10 Monoclonal Antibodies and Methods for Their Use
Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-like Protein (MLP) as a Biomarker for Ovarian and Pancreatic Cancer
Application:
62/347,824 →
Mixed Micelles
Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2
Application:
14/615,355 →
Publication:
US US20150191528A1
Human Kunitz-Type Inhibitor with Enhanced Antifibrinolytic Activity
Dual Reactivity Potent Kunitz Inhibitor of Fibrinolysis
Application:
14/213,828 →
Publication:
US US20140288000A1
Genetically Modified Non-Human Mammals and Cells
Application:
14/316,235 →
Publication:
US US20150067897A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/334,081 →
Publication:
US US20170233493A1
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
Application:
14/168,785 →
Publication:
US US20140205598A1
Methods for Treating Conditions Associated with Masp-2 Dependent Complement Activation
Application:
14/459,656 →
Publication:
US US20150064176A1
Compositions for Inhibiting Masp-2 Dependent Complement Activation
MASP-2, A Complement Fixing Enzyme, and Uses for It
Application:
15/227,479 →
Publication:
US US20170037150A1
Antibodies to Masp-2
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
14/581,191 →
Publication:
US US20150239985A1
Methods for Identifying Inhibitors of Mannan-Binding Lectin-Associated Serine Protease (Masp) Proteins and Uses Thereof
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Application:
13/857,391 →
Publication:
US US20130273053A1
Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
Application:
14/207,143 →
Publication:
US US20140363433A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
13/790,756 →
Publication:
US US20140056873A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
15/093,067 →
Publication:
US US20160272727A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
Application:
13/921,139 →
Publication:
US US20130344073A1
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
Application:
62/275,025 →
Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
Application:
14/213,630 →
Publication:
US US20150017162A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
14/517,750 →
Publication:
US US20150166675A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
14/517,761 →
Publication:
US US20150166676A1
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
62/252,814 →
Methods for Inhibiting Angiogenesis in a Subject in Need Thereof
Application:
62/315,857 →
Highly Concentrated Low Viscosity Masp-2 Inhibitory Antibody Formulations, Kits, and Methods
Application:
62/382,156 →
Compositions and Methods of Inhibiting MASP-3 for the Treatment of Various Diseases and Disorders
Application:
62/369,674 →
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Application:
62/406,726 →
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
Application:
62/407,979 →
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
Processes and Intermediates for the Preparation of a PDE10 Inhibitor
Solid State Forms of a PDE10 Inhibitor
Application:
62/251,074 →
PDE10 Inhibitors and Related Compositions and Methods
Optically Active PDE10 Inhibitor
Optically Active PDE10 Inhibitor
Use of PDE7 Inhibitors for the Treatment of Movement Disorders
Application:
12/974,693 →
Publication:
US US20110091388A1
Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
Application:
13/290,868 →
Publication:
US US20120115849A1
Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
Application:
14/960,750 →
Publication:
US US20160158247A1
G Protein Coupled Receptors and Uses Thereof
Application:
15/007,805 →
Publication:
US US20160282365A1
G Protein Coupled Receptors and Uses Thereof
Application:
14/633,554 →
Publication:
US US20160219845A1
Method of Identifying Transmembrane Protein-interacting Compounds
Application:
14/657,754 →
Publication:
US US20150377896A1
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Application:
14/984,031 →
Publication:
US US20160184272A1
Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
Application:
14/933,633 →
Publication:
US US20160067219A1
Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
Application:
14/937,002 →
Publication:
US US20160120846A1
Ophthalmologic Irrigation Solutions and Method
Ophthalmologic Irrigation Solutions and Method
Application:
15/198,208 →
Publication:
US US20170100412A1
Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
Application:
14/947,107 →
Publication:
US US20160166555A1
Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
Stable Anti-inflammatory Solutions for Injection
Application:
14/971,154 →
Publication:
US US20160166696A1
Stable Preservative-Free Mydriatic and Anti-Inflammatory Solutions for Injection
Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
Application:
14/953,806 →
Publication:
US US20160279099A1
Compositions and Methods for Prophylaxis and Treatment of Addictions
Application:
12/722,429 →
Publication:
US US20160331729A9
Compositions and Methods for Prophylaxis and Treatment of Addictions
Andrographis Paniculata Compositions and Methods for Treatment of Addictions
Application:
13/934,659 →
Publication:
US US20140072662A1
B Cells Modified to Reversibly Induce Accelerated Mutagenesis of Target Genes
Inducible Mutagenesis of Target Genes
Generation of Anti-FN14 Monoclonal Antibodies by Ex-Vivo Accelerated Antibody Evolution
Generation of Anti-FN14 Monoclonal Antibodies by Ex-Vivo Accelerated Antibody Evolution
Anti-FZD10 Monoclonal Antibodies and Methods for Their Use
Compositions and Methods for Systemic Inhibition of Cartilage Degradation
Injectable Drug Delivery Systems with Cyclodextrin-Polymer Based Hydrogels
Biodegradable Triblock Copolymers, Synthesis Methods Therefore, and Hydrogels and Biomaterials Made There From
Mixed Micelles
Soft Tissue Repair System
Tendon Repair Using Adhesive
Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2
Genetically Modified Non-Human Mammals and Cells
Methods for Treating Conditions Associated with Masp-2 Dependent Complement Activation
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting Masp-2 Dependent Complement Activation
Methods for Treating Conditions Associated with Masp-2 Dependent Complement Activation
Compositions for Inhibiting Masp-2 Dependent Complement Activation
Compositions for Inhibiting Masp-2 Dependent Complement Activation
Masp-2, a Complement-Fixing Enzyme, and Uses for It
Masp-2, a Complement-Fixing Enzyme, and Uses for It
Masp-2, a Complement-Fixing Enzyme, and Uses for It
Masp 2, a Complement-Fixing Enzyme, and Uses for It
Masp-2, a Complement Fixing Enzyme, and Uses for It
Antibodies to Masp-2
Masp-2,A Complement-Fixing Enzyme, and Uses for It
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
Methods for Identifying Inhibitors of Mannan-Binding Lectin Associated Serine Protease (Masp) Proteins and Uses Thereof
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
PDE10 Inhibitors and Related Compositions and Methods
Use of PDE7 Inhibitors for the Treatment of Movement Disorders
Use of PDE7 Inhibitors for the Treatment of Movement Disorders
1,3,5-Trisubstituted-5-Phenyl and 5-Pyridyl Pyrazolopyrimidinone Derivatives Having PDE7 Inhibiting Action
Thienopyrazole Derivative Having PDE7 Inhibitory Activity
Thienopyrazole Derivative Having PDE7 Inhibitory Activity
Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
Method of Identifying a Compound for the Treatment or Prevention of Obesity
Method of Identifying Transmembrane Protein-Interacting Compounds
Method of Identifying Transmembrane Protein-Interacting Compounds
Method of Identifying Transmembrane Protein-Interacting Compounds
Method of Identifying Transmembrane Protein-Interacting Compounds
Vectors and Methods for the Mutagenesis of Mammalian Genes
Patent:
6,228,639 →
Application:
09/002,046 →
Vectors and Methods for the Mutagenesis of Mammalian Genes
Method of Inhibition of Pain and Inflammation During Surgery Comprising Administration of Soluble Tnf Receptors
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibiton of pain and inflammation
Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
Arthroscopic Irrigation Solution and Method for Peripheral Vasoconstriction and Inhibition of Pain and Inflammation
Ophthalmologic Irrigation Solutions and Method
Ophthalmologic Irrigation Solutions and Method
Ophthalmologic Irrigation Solutions and Method
Ophthalmologic Irrigation Solutions and Method
Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
Compositions and Methods for Prophylaxis and Treatment of Addictions
Rotational Intrathecal Analgesia
Processes and Intermediates for the Preparation of a PDE10 Inhibitor
PCT:
PCT/US2015/027647 ↗
PDE10 Inhibitors and Related Compositions and Methods
PCT:
PCT/US2016/028973 ↗
Optically Active PDE10 Inhibitor
PCT:
PCT/US2015/027645 ↗
Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
PCT:
PCT/US2015/062929 ↗
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 16, 2013
From: MAIZELS, NANCY
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 031027/0978 →
Assignment of Assignor's Interest
Aug 16, 2013
From: ALLISON, DANIEL S.; CUMMINGS, W. JASON; LEPPARD, JOHN B.; TJOELKER, LARRY W.
To: OMEROS CORPORATION
Reel/Frame 031028/0291 →
Corrective Assignment to Correct the 5TH Inventor's Middle Name Previously Recorded on Reel 031028 Frame 0291. Assignor(S) Hereby Confirms the Middle Name of the 5TH Inventor Listed as Louise Should Be Corrected to L.
Aug 20, 2013
From: ALLISON, DANIEL S.; CUMMINGS, W. JASON; LEPPARD, JOHN B.; TJOELKER, LARRY W.
To: OMEROS CORPORATION
Reel/Frame 031049/0956 →
Assignment of Assignor's Interest
Jan 8, 2014
From: DEMOPULOS, GREGORY A.; DUDLER, THOMAS; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 031920/0382 →
Assignment of Assignor's Interest
Jan 9, 2014
From: DEMOPULOS, GREGORY A.; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 031931/0691 →
Assignment of Assignor's Interest
Feb 25, 2014
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 032296/0899 →
Assignment of Assignor's Interest
Feb 26, 2014
From: TEDFORD, CLARK E.; PARENT, JAMES BRIAN; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 032306/0934 →
Assignment of Assignor's Interest
Feb 26, 2014
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 032305/0693 →
Assignment of Assignor's Interest
Feb 26, 2014
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: UNIVERSITY OF LEICESTER; OMEROS CORPORATION
Reel/Frame 032307/0001 →
Assignment of Assignor's Interest
Jun 9, 2014
From: BAJAJ, S. PAUL
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 033108/0004 →
Assignment of Assignor's Interest
Sep 15, 2014
From: CUMMINGS, W. JASON; GRAY, PATRICK; TJOELKER, LARRY; YABUKI, MUNEHISA
To: OMEROS CORPORATION
Reel/Frame 033739/0045 →
Assignment of Assignor's Interest
Dec 11, 2015
From: LARSEN, FLEMMING; WAHLERS, ULLA
To: HELION BIOTECH APS
Reel/Frame 037277/0605 →
Assignment of Assignor's Interest
Mar 11, 2016
From: MAIZELS, NANCY; CUMMINGS, W. JASON; YABUKI, MUNEHISA
To: UNIVERSITY OF WASHINGTON
Reel/Frame 037957/0302 →
Confirmatory License
Jun 13, 2016
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038972/0891 →
Confirmatory License
Jun 22, 2016
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039113/0495 →
Confirmatory License
Jun 23, 2016
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039128/0117 →
Confirmatory License
Dec 29, 2016
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041210/0202 →
Assignment of Assignor's Interest
Sep 14, 2017
From: SCHWAEBLE, HANS-WILHELM; UNIVERSITY OF LEICESTER
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 043595/0700 →
Assignment of Assignor's Interest
Sep 14, 2017
From: DEMOPULOS, GREGORY A.; OMEROS CORPORATION
To: OMEROS CORPORATION; UNIVERSITY OF LEICESTER
Reel/Frame 043595/0689 →
Assignment of Assignor's Interest
Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
Release of Security Interest
Nov 15, 2018
From: CRG SERVICING LLC
To: OMEROS CORPORATION
Reel/Frame 047573/0577 →
Security Interest
Jun 3, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 067607/0108 →
Corrective Assignment to Correct the Correct the Box Titled"This Document Serves as an Oath/Declaration (37 Cfr 1.63)" Was Erroneously Checked and This Box Should Not Have Been Checked, Previously Recorded at Reel: 67607 Frame: 108. Assignor(S) Hereby Confirms the Security Interest.
Dec 11, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 069715/0719 →
Release of Security Interest
Nov 25, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: OMEROS CORPORATION
Reel/Frame 073705/0970 →